Document:

Prepared by R.R. Donnelley Financial -- Form of Voting Agreement between RITA and Horizon Medical

 EXHIBIT 10.4 
  
 VOTING AGREEMENT 
  
 This Voting Agreement (the “Agreement”) is made and entered into as of May 12, 2004, between RITA Medical Systems, Inc., a Delaware corporation
(“Parent”), Horizon Medical Products, Inc., a Georgia corporation (the “Company”), and the undersigned shareholder of the Company (“Holder”). 
  
 RECITALS 
  
 Pursuant to an Agreement and Plan of Merger dated as of May 12, 2004 (the “Merger Agreement”) by and among Parent, Hornet Acquisition Corp. a
Delaware corporation and wholly-owned subsidiary of Parent (“Merger Sub”), and the Company, Merger Sub is merging with and into the Company (the “Merger”) and the Company, as the surviving corporation of the Merger, will thereby
become a wholly-owned subsidiary of Parent. Concurrently with the execution and delivery of the Merger Agreement and as a condition and inducement to Parent and Merger Sub to enter into the Merger Agreement, Parent has required that Holder enter
into this Agreement. The Holder is the record and beneficial owner of such number of shares of the outstanding Common Stock, $0.001 par value per share, of the Company as is indicated beneath Holder’s signature on the last page of this
Agreement (the “Shares”). 
  
 AGREEMENT

  
 The parties agree as follows: 
  
 1. AGREEMENT TO RETAIN SHARES. 
  
 (a) TRANSFER AND ENCUMBRANCE. (1) Except as contemplated by the Merger
Agreement, and except as provided in Section 1(b) below, during the period beginning on the date hereof and ending on the earlier to occur of (i) the Effective Time (as defined in the Merger Agreement), and (ii) the Expiration Date (as defined
below), Holder agrees not to, directly or indirectly, transfer (except as may be specifically required by court order), sell, exchange, tender, pledge, assign, contribute to the capital of any entity, hypothecate or otherwise dispose of (including
by merger, consolidation or otherwise by operation of law) or encumber the Shares or any New Shares (as defined below), or to, directly or indirectly, make any offer or agreement relating thereto, (2) Holder agrees not to, directly or indirectly,
grant any proxies or powers of attorney, deposit any of such Holder’s Shares into a voting trust or enter into a voting agreement with respect to any of such Holder’s Shares, or enter into any agreement or arrangement providing for any of
the actions described in this clause (2) and (3) Holder agrees not to, directly or indirectly, take any action that could reasonably be expected to have the effect of preventing or disabling Holder from performing Holder’s obligations under
this Agreement at any time prior to the earlier to occur of (i) the Effective Time, and (ii) the Expiration Date. As used herein, the term “Expiration Date” shall mean the earlier to occur of (i) the date of termination of the Merger
Agreement in accordance with the terms and provisions thereof and (ii) the date on which the Company’s Board of Directors withdraws or modifies in a manner adverse to Parent or Merger Sub the Company Recommendation (as defined in the Merger
Agreement) in accordance with the requirements of the second sentence of Section 4.3(e) of the Merger Agreement. 

 (b) PERMITTED TRANSFERS. Section 1(a) shall not prohibit a transfer of Shares or New Shares by Holder (i)
in accordance with the provisions of Rule 144 applicable to Holder, (ii) if Holder is an individual (A) to any member of Holder’s immediate family, or to a trust for the benefit of Holder or any member of Holder’s immediate family, or (B)
upon the death of Holder, or (iii) if Holder is a partnership or limited liability company, to one or more partners or members of Holder or to an affiliated Person under common control with Holder; provided, however, that a transfer referred to in
clauses (ii) and (iii) of this sentence shall be permitted only if, as a precondition to such transfer, the transferee agrees in writing to be bound by all of the terms of this Agreement. 
  
 (c) NEW SHARES. Holder agrees that any shares of capital stock of the Company that Holder purchases or with respect to which
Holder otherwise acquires record or beneficial ownership after the date of this Agreement and prior to the earlier to occur of (i) the Effective Time and (ii) the Expiration Date (“New Shares”) shall be subject to the terms and conditions
of this Agreement to the same extent as if they constituted Shares. Holder further agrees that any shares of capital stock of Parent that Holder purchases or with respect to which Holder otherwise acquires record or beneficial ownership after the
date of this Agreement and prior to the earlier to occur of (i) the record date for Parent’s 2005 annual meeting of stockholders and (ii) the Expiration Date (including without limitation shares of capital stock of Parent acquired by Holder as
a result of the Merger) shall be subject to the terms and conditions of Section 2(b) of this Agreement. 
  
 (d) STOP TRANSFER. From and after the date of this Agreement through the term of this Agreement, the Company will not register or otherwise recognize the
transfer (book-entry or otherwise) of any Shares or any certificate or uncertificated interest representing any of Holder’s Shares, except as permitted by, and in accordance with, Section 1(b). 
  
 2. AGREEMENT TO VOTE SHARES. 
  
 (a) Until the earlier to occur of (i) the Effective Time and (ii) the
Expiration Date, at every meeting of the shareholders of the Company called with respect to any of the following, and at every adjournment thereof, and on every action or approval by written consent of the shareholders of the Company with respect to
any of the following, Holder shall vote or consent the Shares and any New Shares (i) in favor of approval of the Merger Agreement and the Merger and (ii) against any proposal for any recapitalization, merger, sale of assets or other business
combination (other than the Merger) between the Company and any person or entity other than Parent or any other action or agreement that could reasonably be expected to result in a breach of any covenant, representation or warranty or any other
obligation or agreement of the Company under the Merger Agreement or Holder under this Agreement or which could reasonably be expected to result in any of the conditions to the Company’s obligations under the Merger Agreement not being
fulfilled. This Agreement is intended to bind Holder as a shareholder of the Company only with respect to the specific matters set forth herein. Except as set forth in clauses (i) and (ii) of this Section 2, Holder shall not be restricted from
voting in favor of, against or abstaining with respect to any other matter presented to the shareholders of the Company. 
  

 2 

 (b) At each of the 2004 and 2005 annual meeting of stockholders of Parent, and at any adjournment or
postponement of either such meeting, Holder shall vote all shares of capital stock of Parent owned beneficially or of record by Holder as of the record date for each such annual meeting in favor of the election of the nominees for director
recommended for election by the Board of Directors of Parent; provided, however, that Holder shall have no obligation under this Section 2(b) in the event that the Expiration Date occurs prior to either such annual meeting of stockholders; provided
further, that Holder shall have no obligation under this Section 2(b) with respect to the 2005 annual meeting of stockholders of Parent if (i) the individual designated by the Company pursuant to section 5.17(a) of the Merger Agreement to serve as a
Class II director of Parent is willing, able and qualified to serve as a director of Parent and is not one of the nominees the Board of Directors of Parent recommends for election at the 2005 annual meeting of stockholders of Parent or (ii)
Parent’s compensation policy with respect to non-employee directors is modified in any material respect prior to the 2005 annual meeting of stockholders of Parent. Notwithstanding the foregoing, nothing in this Agreement, including without
limitation this Section 2(b), shall restrict Holder’s ability to sell, transfer or otherwise dispose of shares of the capital stock of Parent following the Effective Time, and no transferee of shares of the capital stock of Parent beneficially
owned by Holder shall have any obligation under this Agreement after the Effective Time. 
  
 3. IRREVOCABLE PROXY. Concurrently with the execution of this Agreement, Holder agrees to deliver to Parent a proxy in the form attached hereto as Exhibit A (the “Proxy”), which shall be irrevocable to the
extent provided in the Georgia Business Corporation Code covering the Shares and New Shares. 
  
 4. REPRESENTATIONS, WARRANTIES AND COVENANTS OF HOLDER. Holder hereby represents, warrants and covenants to Parent that Holder (i) is the record and beneficial owner of the Shares, which, at the date of this Agreement
and at all times up until the earlier to occur of (A) the Effective Time, and (B) the Expiration Date, will be free and clear of any liens, claims, options, charges or other encumbrances, and (ii) does not own of record or beneficially any shares of
capital stock of the Company other than the Shares (excluding shares as to which Holder currently disclaims beneficial ownership in accordance with applicable law). Holder has the legal capacity, power and authority to enter into and perform all of
Holder’s under this Agreement (including under the Proxy). This Agreement (including the Proxy) has been duly and validly executed and delivered by Holder and constitutes a valid and binding agreement of Holder, enforceable against Holder in
accordance with its terms, subject to (a) laws of general application relating to bankruptcy, insolvency and the relief of debtors and (b) rules of law governing specific performance, injunctive relief and other equitable remedies. [IF HOLDER IS
MARRIED AND HOLDER’S SHARES CONSTITUTE COMMUNITY PROPERTY, THIS AGREEMENT (INCLUDING THE PROXY) HAS BEEN DULY AUTHORIZED, EXECUTED AND DELIVERED BY, AND CONSTITUTES A VALID AND BINDING AGREEMENT OF, HOLDER’S SPOUSE, ENFORCEABLE AGAINST
SUCH PERSON IN ACCORDANCE WITH ITS TERMS.] [DELETE IF INAPPLICABLE.] 
  
 5. ADDITIONAL DOCUMENTS. Holder hereby covenants and agrees to execute and deliver any additional documents reasonably necessary to carry out the purpose and intent of this Agreement. 
  

 3 

 6. CONSENT AND WAIVER. Holder hereby gives any consents or waivers that are reasonably required for the
consummation of the Merger under the terms of any agreement to which Holder is a party or pursuant to any rights Holder may have. 
  
 7. TERMINATION. This Agreement and the Proxy delivered in connection herewith shall terminate and shall have no further force or effect as of the earlier
to occur of (i) the Expiration Date and (ii) the date following the date of the 2005 annual meeting of stockholders of Parent, including any adjournment or postponement thereof. 
  
 8. FIDUCIARY DUTIES. Notwithstanding anything in this Agreement to the contrary: (i) Holder makes no agreement or
understanding herein in any capacity other than in Holder’s capacity as a record holder and beneficial owner of the Shares, (ii) nothing in this Agreement shall be construed to limit or affect any action or inaction by Holder, or any officer,
partner, member or employee, as applicable, of Holder, serving on the Company’s Board of Directors acting in such person’s capacity as a director or fiduciary of the Company, and (iii) Holder shall have no liability to Parent, Merger Sub
or any of their respective affiliates under this Agreement as a result of any action or inaction by Holder, or any officer, partner, member or employee, as applicable, of Holder, serving on the Company’s Board of Directors acting in such
person’s capacity as a director or fiduciary of the Company. 
  
 9. MISCELLANEOUS. 
  
 (a) AMENDMENTS AND WAIVERS. Any
term of this Agreement may be amended or waived with the written consent of the parties or their respective successors and assigns. Any amendment or waiver effected in accordance with this Section 9(a) shall be binding upon the parties and their
respective successors and assigns. 
  
 (b) GOVERNING LAW. This
Agreement and all acts and transactions pursuant hereto and the rights and obligations of the parties hereto shall be governed, construed and interpreted in accordance with the laws of Delaware, without giving effect to principles of conflicts of
law. 
  
 (c) COUNTERPARTS. This Agreement may be executed in two
or more counterparts, each of which shall be deemed an original and all of which together shall constitute one instrument. 
  
 (d) TITLES AND SUBTITLES. The titles and subtitles used in this Agreement are used for convenience only and are not to be considered in construing or
interpreting this Agreement. 
  
 (e) NOTICES. Any notice required
or permitted by this Agreement shall be in writing and shall be deemed sufficient upon receipt, when delivered personally or by courier, overnight delivery service or confirmed facsimile, or 72 hours after being deposited in the regular mail as
certified or registered mail (airmail if sent internationally) with postage prepaid, if such notice is addressed to the party to be notified at such party’s address or facsimile number as set forth below, or as subsequently modified by written
notice. 
  

 4 

 (f) SEVERABILITY. If one or more provisions of this Agreement are held to be unenforceable under
applicable law, the parties agree to renegotiate such provision in good faith, in order to maintain the economic position enjoyed by each party as close as possible to that under the provision rendered unenforceable. In the event that the parties
cannot reach a mutually agreeable and enforceable replacement for such provision, then (i) such provision shall be excluded from this Agreement, (ii) the balance of the Agreement shall be interpreted as if such provision were so excluded and (iii)
the balance of the Agreement shall be enforceable in accordance with its terms. 
  
 (g) SPECIFIC PERFORMANCE. Each of the parties hereto recognizes and acknowledges that a breach of any covenants or agreements contained in this Agreement will cause Parent and Merger Sub to sustain damages for which
they would not have an adequate remedy at law for money damages, and therefore each of the parties hereto agrees that in the event of any such breach Parent shall be entitled to the remedy of specific performance of such covenants and agreements and
injunctive and other equitable relief in addition to any other remedy to which they may be entitled, at law or in equity. 
  
 [SIGNATURE PAGE FOLLOWS] 
  

 5 

 The parties have caused this Agreement to be duly executed on the date first above written. 

 

			
	PARENT	 	 
		
	By:	 	  

	Name:	 	  

	Title:	 	  

	Address:	 	RITA Medical Systems, Inc.
	 	 	967 North Shoreline Blvd.
	 	 	Mountain View, CA 94043
	Attention:	 	Joseph DeVivo, President and Chief Executive Officer
	Facsimile No.:	 	(650) 967-1691
		
	COMPANY	 	 
		
	By:	 	  

	Name:	 	  

	Title:	 	  

	Address:	 	Horizon Medical Products, Inc.
	 	 	One Horizon Way
	 	 	Manchester, GA 91816
	Attention:	 	Robert Wenzel, President
	Facsimile No.:	 	(706) 846-5226

  
 SIGNATURE PAGE TO
VOTING AGREEMENT 

			
	HOLDER
		
	By:	 	  

	Name:	 	  

	Title:	 	  

	
	Holder’s Address for Notice:
	  

	  

	  

  

							
	 Shares owned of record:

	  	 Beneficially owned shares:

	 Class of Shares

	  	 Number

	  	 Class of Shares

	  	 Number

	 	  	 	  	 	  	 
	 	  	 	  	 	  	 

  
 SIGNATURE PAGE TO
VOTING AGREEMENT 

 EXHIBIT A 
  

IRREVOCABLE PROXY 
  
 TO VOTE STOCK OF 
  
 HORIZON MEDICAL PRODUCTS, INC. 
  
 AND 
  
 RITA MEDICAL SYSTEMS, INC. 
  
 The undersigned shareholder of Horizon Medical Products, Inc. a Georgia corporation (the “Company”), hereby irrevocably (to the full extent permitted by the Georgia Business Corporation Code) appoints the
Chief Executive Officer and Chief Financial Officer of RITA Medical Systems, Inc. a Delaware corporation (“Parent”), and each of them, as the sole and exclusive attorneys and proxies of the undersigned, with full power of substitution and
resubstitution, to vote and exercise all voting and related rights (to the full extent that the undersigned is entitled to do so) with respect to all of the shares of capital stock of the Company and all of the shares of capital stock of Parent that
now are or hereafter may be owned of record or beneficially by the undersigned, and any and all other shares or securities of the Company (collectively, the “Company Shares”) or Parent (collectively, the “Parent Shares” and
together with the Company Shares, the “Shares”) issued or issuable in respect thereof on or after the date hereof in accordance with the terms of this Proxy and that certain Voting Agreement of even date herewith, by and among Parent, the
Company and the undersigned (the “Voting Agreement”). The shares of the capital stock of the Company owned by the undersigned shareholder of the Company as of the date of this Proxy are listed beneath the undersigned’s signature on
the final page of this Proxy. Upon the undersigned’s execution of this Proxy, any and all prior proxies given by the undersigned with respect to any Shares are hereby revoked and the undersigned agrees not to grant any subsequent proxies with
respect to the Shares until after the earlier to occur of (i) the Expiration Date (as defined below) and (ii) the Effective Time (after which time the undersigned agrees not to grant any proxy with respect to shares of the capital stock of Parent in
a manner inconsistent with this Proxy). 
  
 This Proxy is coupled
with an interest, is irrevocable (to the extent permitted by the Georgia Business Corporation Code in the case of the capital stock of the Company and, in the case of the capital stock of Parent, the Delaware General Corporation Law), is granted
pursuant to the Voting Agreement, and is granted in consideration of Parent entering into that certain Agreement and Plan of Merger, of even date herewith, by and among the Company, Parent and Hornet Acquisition Corp., a Delaware corporation
(“Merger Sub”) and wholly-owned subsidiary of Parent (the “Merger Agreement”). The Merger Agreement provides for the merger of Merger Sub with and into the Company (the “Merger”). As used herein, the term
“Expiration Date” shall mean the earlier to occur of (i) the date of termination of the Merger Agreement in accordance with the terms and provisions thereof and (ii) the date on which the Company’s Board of Directors withdraws 

 
or modifies in a manner adverse to Parent or Merger Sub the Company Recommendation (as defined in the Merger Agreement) in accordance with the requirements
of the second sentence of Section 4.3(e) of the Merger Agreement. 
  
 The attorneys and proxies named above, and each of them, are hereby further authorized and empowered by the undersigned, at any time prior to the earlier to occur of (i) the Effective Time and (ii) Expiration Date, to act as the
undersigned’s attorney and proxy to vote the Shares, and to exercise all voting and other rights of the undersigned with respect to the Shares (including, without limitation, the power to execute and deliver written consents pursuant to the
Georgia Business Corporation Code), at every annual, special or adjourned meeting of the shareholders of the Company and in every written consent in lieu of such meeting (i) in favor of approval of the Merger and the Merger Agreement and (ii)
against any proposal for any recapitalization, merger, sale of assets or other business combination (other than the Merger) between the Company and any person or entity other than Parent or any other action or agreement that could reasonably be
expected to result in a breach of any covenant, representation or warranty or any other obligation or agreement of the Company under the Merger Agreement or the undersigned under the Voting Agreement or which could reasonably be expected to result
in any of the conditions to the Company’s obligations under the Merger Agreement not being fulfilled. 
  
 The attorneys and proxies named above, and each of them, are hereby authorized and empowered by the undersigned, at any time prior to the earlier to occur
(i) the Expiration Date and (ii) the date following the date of the 2005 annual meeting of stockholders of Parent, including any adjournment or postponement thereof, to act as the undersigned’s attorney and proxy to vote all Parent Shares owned
beneficially or of record by the undersigned as of the record date for each annual meeting of Parent stockholders, and to exercise all voting and other rights of the undersigned with respect to such shares (including, without limitation, the power
to execute and deliver written consents pursuant to the Delaware General Corporation Law), at every annual meeting of the stockholders of Parent, including any adjournment or postponement thereof, in favor of the election of nominees to the Board of
Directors of Parent recommended for election by the Board of Directors of Parent. 
  
 Any obligation of the undersigned hereunder shall be binding upon the successors and assigns of the undersigned. 
  
 This Proxy is irrevocable (with respect to the shares of capital stock of the Company, to the extent provided in the Georgia Business Corporation Code
and, with respect to the shares of capital stock of Parent, to the extent provided in the Delaware General Corporation Law). 
  
 [SIGNATURE PAGE FOLLOWS] 
  

 2 

			
	Dated:	 	May __, 2004
	  

 (Signature of
Holder)

	  

 (Print Name of
Holder)

	  

 (Title of Signatory if
Holder is an Entity)

  

							
	 Shares owned of record:

	  	 Beneficially owned shares:

	 Class of Shares

	  	 Number

	  	 Class of Shares

	  	 Number

	 	  	 	  	 	  	 
	 	  	 	  	 	  	 

  
 SIGNATURE PAGE TO
IRREVOCABLE PROXYPrepared by R.R. Donnelley Financial -- Admt. No. 4 to Note Purchase Agreement dated as of May 12, 2004

 EXHIBIT 10.5 
  
 AMENDMENT NO. 4 TO NOTE PURCHASE AGREEMENT 
  
 This Amendment No. 4 to Note Purchase Agreement (this “Amendment”), dated as of May 12, 2004, amends that certain
Note Purchase Agreement, dated as of March 1, 2002, by and among Horizon Medical Products, Inc., a Georgia corporation (the “Company”); ComVest Venture Partners, L.P., a Delaware limited partnership (“ComVest,” and together with
its successors and assigns, the “Purchaser”), and the Additional Note Purchasers (as defined therein), as amended by Amendment No. 1 to Note Purchase Agreement, dated as of June 10, 2002, Amendment No. 2 to Note Purchase Agreement, dated
as of July 29, 2002, and Amendment No. 1 to Note Purchase Agreement dated as of October 21, 2003 (as amended, the “Note Purchase Agreement”). Capitalized terms used in this Amendment but not defined herein have the meanings given to such
terms in the Note Purchase Agreement. 
  
 WHEREAS,
the Company has requested an extension of the time to repay the indebtedness and certain other modifications to the Note Purchase Agreement; and 
  
 WHEREAS, the Purchaser and Medtronic, Inc. (“Medtronic”) have agreed to such modification subject to the terms and conditions set
forth herein; and 
  
 WHEREAS, the other Additional
Note Purchasers have the right, but not the obligation, to become parties to this Amendment. 
  
 NOW, THEREFORE, in consideration of the premises and mutual covenants of the parties hereunder, the Company, the Purchaser and the Electing Noteholders (as defined below) agree as
follows: 
  
 Section 1. Amendments. The Note Purchase
Agreement and, to the extent applicable, the Notes are hereby modified as follows: 
  
 (a) The definition of “Maturity Date” is hereby deleted in its entirety and replaced with the following: 
  
 “ “Maturity Date” means (i) with
respect to the Electing Notes, July 16, 2008 and (ii) with respect to the Non-Electing Notes, July 16, 2005.” 
  
 (b) The following definitions are hereby added to Section 1 of the Note Purchase Agreement: 
  
 “ “Electing Noteholders” means
the Purchaser, Medtronic, and each Additional Note Purchaser who is a party to this Amendment.” 
  
 “ “Electing Notes” means the Purchaser Senior Subordinated Convertible Note, the Medtronic Additional Note, and
the Additional Notes held by the Electing Noteholders.” 

 “ “Medtronic Co-Marketing Agreement” means that certain
Co-Promotion Agreement dated as of March 15, 2002, between Medtronic and the Company, and as amended by that amendment thereto dated as of April 15, 2003.” 
  
 “ “Merger” means the Merger (as defined in the Merger Agreement) and the other
transactions contemplated by the Merger Agreement.” 
  
 “ “Merger Agreement” means the Agreement and Plan of Merger, dated May 12, 2004, by and among RITA MEDICAL SYSTEMS, INC., a Delaware corporation (“Parent”), HORNET ACQUISITION
CORP., a Delaware corporation and a wholly-owned subsidiary of Parent, and the Company.” 
  
 “ “Merger Closing Date” means the Closing Date as defined in the Merger Agreement.” 
  
 “ “Non-Electing Notes” means the
Additional Notes held by the Additional Note Purchasers who do not execute this Amendment as Electing Noteholders.” 
  
 (c) Section 2.1(a) is hereby deleted in its entirety and replaced with the following: 
  
 “(a)(i) The Company has duly authorized the issue, sale
and delivery of (A) its Purchaser Senior Subordinated Convertible Note, in the aggregate principal amount of $4,400,000, to be dated the date of issue thereof, (B) its Medtronic Additional Note, in the aggregate principal amount of $4,000,000, to be
dated the date of issue thereof and (C) its Additional Notes, in the aggregate principal amount of up to $6,600,000, to be dated the date of issue thereof. 
  
 (ii) Each of the Electing Notes shall bear interest from such date on the unpaid principal amount thereof (calculated on the basis of a
360-day year and actual days elapsed) at a rate per annum equal to (A) 6% per annum from the date thereof to and including the date that is the six month anniversary of the Closing Date, (B) 8% per annum from the date that is the six month
anniversary of the Closing Date until the first anniversary of the Merger Closing Date, and (C) 14% from the first anniversary of the Merger Closing Date until such time as the Electing Notes shall have been paid in full, such interest to be payable
quarterly in arrears on the fifth day of each month (commencing on the date that is the three month anniversary of the Closing Date), and at maturity, to bear interest, payable on demand, on any overdue principal and, to the extent permitted by
applicable law, on any overdue interest, fees and other overdue amounts payable hereunder until the same shall be paid, at a variable rate per 

 annum equal to the sum of 3.00% plus the rate that would at the time be applicable under the foregoing
provisions to principal amounts not overdue and, in the case of each of the Electing Notes, to mature on the Maturity Date, and to be substantially in the form of Exhibit B hereto; 
  
 (iii) Each of the Non-Electing Notes shall bear interest from such date on the unpaid principal amount
thereof (calculated on the basis of a 360-day year and actual days elapsed) at a rate per annum equal to (A) 6% per annum from the date thereof to and including the date that is the six month anniversary of the Closing Date and (B) 8% per annum from
the date that is the six month anniversary of the Closing Date until such time as the Non-Electing Notes shall have been paid in full, such interest to be payable quarterly in arrears on the fifth day of each month (commencing on the date that is
the three month anniversary of the Closing Date), and at maturity, to bear interest, payable on demand, on any overdue principal and, to the extent permitted by applicable law, on any overdue interest, fees and other overdue amounts payable
hereunder until the same shall be paid, at a variable rate per annum equal to the sum of 3.00% plus the rate that would at the time be applicable under the foregoing provisions to principal amounts not overdue and, in the case of each of the
Non-Electing Notes, to mature on the Maturity Date, and to be substantially in the form of Exhibit B hereto;” 
  
 (d) Section 3.1(a) is hereby deleted in its entirety and replaced with the following: 
  
 “(a) Subject to the provisions of this Section 3.1(a),
the Company at its option may, after giving not less than three (3) days’ prior written notice (the “Company Conversion Notice”) to the Purchaser and each Additional Note Purchaser, prepay the unpaid principal balance of the
Notes, together with all accrued but unpaid interest on the principal amount being prepaid to the date of such prepayment, in whole or in part (in an aggregate amount of not less than $1,000,000 or any greater amount which is an even multiple of
$100,000, or in an amount equal to the aggregate principal balance of all of the Notes) as set forth below. It is also expressly understood and agreed by the Company that, notwithstanding anything to the contrary contained herein or in any other
Note Document, each holder of a Note shall have the right to convert such Note as provided in this Agreement notwithstanding the giving by the Company of any 3-day notice of prepayment under this Section 3.1(a) if such holder of a Note shall give to
the Company the Company Conversion Notice or the Default Conversion Notice, as the case may be.” 
  
 (e) The following Section 11.5 is hereby added to the Note Purchase Agreement: 
  
 “Section 11.5. Estoppel. 

 (a) The Requisite Noteholders, on behalf of themselves and the Additional Note
Purchasers, hereby acknowledge and agree that, as of May 12, 2004: (i) this Agreement and all covenants, rights and obligations contained herein are in full force and effect; (ii) to their knowledge, no breach or default on the part of the Company
exists under this Agreement or the Notes; and (iii) to their knowledge, no event has occurred and no condition exists which, with the giving of notice or lapse of time or both, could constitute such a default or would otherwise entitle any party to
this Agreement or the holder of any of the Notes to declare any breach or default under the Agreement, including without limitation any event or condition that constitutes or could constitute an Event of Default, on the part of the Company. The
Requisite Noteholders further acknowledge and agree, on behalf of themselves and the Additional Note Purchasers, that the statements set forth in this Section 11.5 shall act as a waiver of any claim by any party to this Agreement or the holder of
any of the Notes, to the extent such claim is based upon facts contrary to those asserted in this Section 11.5. 
  
 (b) Notwithstanding any provision in this Agreement to the contrary, neither Medtronic nor the Requisite Noteholders shall be permitted to
declare an Event of Default under Section 11.1 of this Agreement in respect of any breach, default or condition that occurs or exists prior to the expiration of the Pre-Closing Period, unless such breach, default or condition giving rise to such
Event of Default, either alone or together with any other breach, default or condition giving rise to any other Event of Default, has, or is reasonably likely to have, a Material Adverse Effect. For purposes of this Section 11.5(b),
“Pre-Closing Period” means the period beginning on May 12, 2004 and ending immediately before the Effective Time (as defined in the Merger Agreement).” 
  
 Section 2. Merger Consent. Notwithstanding any provision in the Note Purchase Agreement to the contrary, including,
without limitation, Sections 9.8, 10.3 and 11.1, ComVest and Medtronic, representing the Requisite Noteholders, hereby consent to the Merger and acknowledge that neither the Merger nor any of the transactions contemplated in the Merger Agreement
will constitute an Event of Default under the Note Purchase Agreement. 
  
 Section 3. Effective Date. This Amendment will become effective as to the Purchaser, Medtronic and each other Electing Noteholder as of the Effective Time (as defined in the Merger Agreement); provided, however, that the amendments
set forth in Section 1(e) above shall be effective as of the date hereof. 
  
 Section 4. Continuing Effect. Except as expressly amended hereby, the Note Purchase Agreement, the Notes and the Additional Notes shall continue to be, and shall remain, in full force and effect in accordance
with its terms. 
  
 Section 5. Governing Law. This
Amendment shall be governed by and construed and interpreted in accordance with the laws of the State of New York. 

 Section 6. Counterparts. This Amendment may be executed in two or more counterparts, each of which
shall be deemed an original but all of which shall together constitute one and the same instrument. 
  
 [signature pages follow] 

 IN WITNESS WHEREOF, the undersigned parties have caused this Amendment to be duly executed by their
respective officers thereunto duly authorized, as of the date first above written. 
  

			
	 COMPANY

	
	 HORIZON MEDICAL PRODUCTS, INC.

		
	 By:
	 	 /s/    ROBERT J. WENZEL

	 	 	Name: Robert J. Wenzel
	 	 	Title: Interim CEO
		
	 PURCHASER
	 	 
	
	 COMVEST VENTURE PARTNERS, L.P.

		
	 By:
	 	 /s/    HAROLD BLUE

	 	 	Name: Harold Blue
	 	 	Title: Partner/President
	
	 MEDTRONIC

	
	 MEDTRONIC, INC.

		
	 By:
	 	 /s/    MICHAEL D. ELLWEIN

	 	 	Name: Michael D. Ellwein
	 	 	Title: Vice President and Chief Development Officer

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00067-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00067-of-00352.parquet"}]]